Leading Oncology Expert Joins Our Hospital: Fan Ruitai, Standing Committee Member of Chinese Society for Radiation Oncology & Former Chairman of Henan Society for Radiotherapy

Recently, Professor Fan Ruitai from the First Affiliated Hospital of Zhengzhou University in Henan Province has officially joined the Wuwei Heavy Ion Center of Gansu Wuwei Cancer Hospital, injecting new and powerful momentum into the center's development in the field of oncology treatment.

Professor Fan Ruitai has achieved remarkable accomplishments in the field of oncology radiotherapy, with profound academic expertise and extensive clinical experience. As a second-level professor, chief physician, and doctoral/postdoctoral supervisor, he holds multiple prestigious positions, including serving as the academic leader of the Key Clinical Specialty of Oncology under the Ministry of Health and the Key Discipline of Oncology in Henan Province. He also plays key roles in numerous national and provincial professional academic organizations, such as being a standing committee member of the Radiation Oncology Committee of the Chinese Medical Association and the chairman of the Radiation Oncology Committee of the Henan Medical Association. Throughout his distinguished medical career, Professor Fan has continuously researched and innovated in tumor radiotherapy techniques, accumulating numerous successful cases. He possesses unique insights and extensive experience in the radiotherapy treatment of various malignant tumors, earning him extremely high prestige within the medical community.

Professor Fan Ruitai participates in the multidisciplinary pre-treatment case conferences held weekly at the Wuwei Heavy Ion Center before patient treatments

The Wuwei Heavy Ion Center of Gansu Wuwei Cancer Hospital is the birthplace of domestically produced heavy ion therapy systems and is hailed in the industry as the "Jinggangshan" of ion radiotherapy. The first domestically manufactured heavy ion device was officially put into clinical use on March 26, 2020. On November 15, 2024, the second domestic heavy ion system began clinical operations, managed by Gansu Wuwei Cancer Hospital. To date, over 2,000 patients have been treated here, with patients coming from all provinces and municipalities across China, as well as attracting patients from Australia, Belgium, South Korea, Malaysia, and other countries seeking treatment. The center has achieved remarkable therapeutic outcomes, accumulated extensive clinical experience in the application of heavy ion therapy technology, and developed a comprehensive tumor treatment system through continuous exploration and innovation.

The photo shows Professor Fan Ruitai leading an expert team during ward rounds for Malaysian patient Datin Maria (pseudonym)

Professor Fan Ruitai's joining aligns perfectly with the long-standing talent development strategy of Gansu Wuwei Cancer Hospital. For many years, the hospital has adhered to the philosophy that talent is the primary resource, cultivating a diverse talent pool that spans the entire heavy ion therapy ecosystem. By integrating Eastern and Western medical wisdom, the hospital has established an expert think tank that serves as a global "idea incubator" for cancer treatment.

We firmly believe that under the leadership of Professor Fan and other industry pioneers, the Wuwei Heavy Ion Center of Gansu Wuwei Cancer Hospital will be propelled by innovation to accelerate its development into an internationally benchmarked heavy ion cancer treatment center that integrates clinical diagnosis and treatment, research translation, and talent cultivation. This will reshape the landscape of cancer therapy, bring new hope to patients worldwide, and powerfully advance China's cancer treatment capabilities to a new level of global leadership.